Showing results (91-100 of 343) with videos related to
Sort By:
Pageof 35
Skeletal Radiology|November 17, 2011
Intrasomatic injection of corticosteroid followed by vertebroplasty increases early pain relief rather than vertebroplasty alone in vertebral bone neoplasms: preliminary experienceAntonio Basile, Salvatore Masala, Giuseppe Banna, et al.BMC Cancer|February 7, 2013
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferationCesarina Giallongo, Piera La Cava, Daniele Tibullo, et al.Acta Oncologica (Stockholm, Sweden)|March 25, 2010
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsFabio Stagno, Paolo Vigneri, Vittorio Del Fabro, et al.Frontiers in Oncology|January 7, 2021
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An OverviewAlessandro Barbato, Grazia Scandura, Fabrizio Puglisi, et al.Annals of Hematology|February 14, 2009
Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasmsDomenica Caramazza, Clementina Caracciolo, Rita Barone, et al.British Journal of Haematology|November 8, 2014
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategyAlessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.Haematologica|March 9, 2004
GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemiaAndrea Camera, Luciana Annino, Federico Chiurazzi, et al.International Journal of Molecular Sciences|November 6, 2019
Monocytic Myeloid Derived Suppressor Cells in Hematological MalignanciesGiuseppe Alberto Palumbo, Nunziatina Laura Parrinello, Cesarina Giallongo, et al.Plos One|July 12, 2014
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patientsCesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, et al.Leukemia Research|October 9, 2017
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II studyGiuseppe Visani, Felicetto Ferrara, Francesco Di Raimondo, et al.Pageof 35